Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06242964 · ClinicalTrials.gov registry record · NA

The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer

A NA study of Cancer and Coping Skills, sponsored by Seattle Children's Hospital.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06242964: Recruiting NA study of Cancer and Coping Skills, sponsored by Seattle Children's Hospital.

NCT06242964 is a NA study of Cancer and Coping Skills that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 100 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06242964, a NA study of Cancer and Coping Skills, is actively recruiting participants, sponsored by Seattle Children's Hospital.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to establish feasibility, acceptability, and proof-of-concept of an psychosocial intervention adapted to address social health needs of adolescents and young adults (AYAs) newly diagnosed with cancer. The aims of this study are to: 1. Determine if the Promoting Resilience in Stress Management - Social Needs (PRISM-SN) adapted intervention is feasible and acceptable, defined via program uptake and retention and patient-reported feedback. 2. Explore whether PRISM-SN improves social outcomes at 12-week follow-up compared to usual care. Participants will be randomized to receive usual psychosocial care or the PRISM-SN program. Participants on both arms will complete patient-reported outcome surveys at enrollment and 12-weeks later. Researchers will compare participants who received the PRISM-SN program to those who received usual care to see if the program improves psychosocial outcomes.

Interventions

  • BEHAVIORAL Promoting Resilience in Stress Management - Social Needs (PRISM-SN)

Study Locations (1)

Washington

  • Seattle Children's - Seattle

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-05-15
Est. Completion 2026-07-31
Phase NA
Seattle Children's Hospital

168 total trials

What NCT06242964 shows while recruiting

NCT06242964 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).

The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Promoting Resilience in Stress Management - Social Needs (PRISM-SN) is the first listed.

NCT06242964 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06242964 about?

NCT06242964 is a clinical study titled "The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer". The goal of this study is to establish feasibility, acceptability, and proof-of-concept of an psychosocial intervention adapted to address social health needs of adolescents and young adults (AYAs) newly diagnosed with cancer. The aims of this study are to: 1. Determine if the Promoting Resilience ...

What is the current status of trial NCT06242964?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-15. Estimated completion is 2026-07-31.

What conditions does trial NCT06242964 study?

This clinical trial studies the following conditions: Cancer, Coping Skills, Psychosocial Functioning, Social Functioning.

What interventions are being tested in trial NCT06242964?

The interventions under investigation include: Promoting Resilience in Stress Management - Social Needs (PRISM-SN) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06242964?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06242964 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06242964's enrollment target sits among peer trials

100 313th of 615 higher than 287 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06242964, the US trial registry maintained by the National Library of Medicine. NCT06242964 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.